about
Complement component 3APOBApolipoprotein BZinc finger CCCH-type containing 12AInhibitor of nuclear factor kappa B kinase subunit epsilonHypoxia inducible lipid droplet associatedNuclear receptor subfamily 1 group H member 2Perilipin 5V-set and transmembrane domain containing 2AAcetyl-CoA carboxylase betaPhospholipase A2 group XZinc finger CCCH type containing 12AInhibitor of kappaB kinase epsilonAcetyl-Coenzyme A carboxylase betaPhospholipase A2, group XHypoxia inducible lipid droplet associatedPerilipin 5Nuclear receptor subfamily 1, group H, member 2Transmembrane protein 135V-set and transmembrane domain containing 2AZinc finger CCCH type containing 12AComplement C3Apolipoprotein BPhospholipase A2, group XPerilipin 5Nuclear receptor subfamily 1, group H, member 2Inhibitor of nuclear factor kappa B kinase subunit epsilonSterol regulatory element Binding Protein CELE_Y47D3B.7Transmembrane protein 135 homolog CELE_K02G10.3Probable metabotropic glutamate receptor mgl-1 CELE_ZC506.4Tripeptidyl-peptidase 2 CELE_F21H12.6Fatty acyl-CoA reductase in oenocytes Dmel_CG18031Unpaired 2 Dmel_CG5988Spidey Dmel_CG1444Akt1 Dmel_CG4006Seipin Dmel_CG9904Grasp65 Dmel_CG7809Phosphatidylinositol 3-kinase 92E Dmel_CG4141Sarco/endoplasmic reticulum Ca(2+)-ATPase Dmel_CG3725Nuclear factor kappa B subunit 1
P682
Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial periodC-reactive protein-bound enzymatically modified low-density lipoprotein does not transform macrophages into foam cellsHypoxia-inducible protein 2 is a novel lipid droplet protein and a specific target gene of hypoxia-inducible factor-1
P921
Q14874319-71B16198-7681-4354-BCEC-D051E71E8E0EQ14890615-6A47C15A-BC0D-418D-AB4A-ED06C26BF869Q14890657-3AF14E02-6B17-43AA-9858-C7D2CF487A20Q21108146-BDE0C2AA-835B-41DF-BA2F-8A59F2F602C8Q21111538-65CF3615-B336-4C84-948F-954F36F11BDDQ21111653-6066E50D-724B-4D90-B3DF-A27DA97FC902Q21115219-F1E16C83-977D-4339-9EED-8CF5C5693869Q21123271-2FC0E1EB-C1F0-4F0D-8B61-D742D32119EDQ21125759-8D903E53-304B-4F27-8CBB-85667EF3D403Q21132362-141F070F-4DAE-4D52-860B-1EF6A34557C1Q21173823-21599845-89A6-4AF3-9863-B008FAD3FF6CQ21173823-AE36CF61-7E2E-422D-A040-A4DF6CF9590DQ21496527-74BB30AD-8817-4EA2-9049-B373E47A8058Q21496531-697880FD-1176-422D-B087-03043568CF48Q21497954-827708E4-B921-40C3-BB8B-D8FD03761DACQ21985197-0F392325-097F-466F-8FF5-2DED085CB54DQ21985197-CDD22197-5AE0-4083-9C26-982F04C5A72DQ21987093-7C9DAAD3-784E-4334-A6DF-16B34BEC10A9Q21988927-E0786029-FBA2-4E9C-9575-1645B0ED51BEQ21989816-1DE7BA25-9A4C-4020-A179-ED54F74D1603Q21992197-8C34CB85-C403-4AE4-9FA2-082C7BDD535BQ21992734-5866488B-7D83-4CD5-B05C-A4E1A1A272ABQ28556326-D3F5876D-1079-46CE-96C0-16F9EE6A6F82Q28557340-95501CCB-D680-4EA6-9BF6-0E4147087815Q28557999-E1D25855-313C-45B8-8B93-D4EAF1568319Q28559120-6AC885C3-1181-4FB2-9FA5-FAE53CEDDEC6Q28560186-1D01661D-7443-4865-B98F-5016BD95C5DEQ28560591-F928600D-1BCF-4CB4-B729-7DD41550BC4FQ29522246-EB415D5A-EC91-4A03-8427-8F2EC610FAC9Q29792236-B134D4FB-1FC6-4DE1-804F-A9E0C20C7A5BQ29794936-B8E9830A-59DD-49B9-8C45-80D828A5A7BEQ29799403-B7316AF6-925D-4081-BE5B-B2134AE8262EQ29805595-F6422603-E532-4C96-B928-7061980EC8CCQ29811172-35D17F27-4DE9-4759-85BC-B87E0241A9E8Q29811714-56E5555D-6C9F-45CA-A692-26ACEFEE94E6Q29814140-1AD84DE2-132D-4C36-A97B-32E3A0028CD9Q29814786-B4406018-0C33-43C7-8328-232F2E1D7032Q29818896-000F7B81-4686-4766-A356-4867294CB61FQ29818930-9ECB335E-EB78-4A00-85F9-02651263F632Q29820517-E8E90E64-C454-48C2-B97A-4452F0737FED
P682
description
Any process that increases the ...... y soluble in aqueous solvents.
@en
biologisch proces
@nl
name
positive regulation of lipid storage
@en
type
label
positive regulation of lipid storage
@en
altLabel
GO:0010884
@en
prefLabel
positive regulation of lipid storage
@en
P128
P2888
P686
GO:0010884